SCHEMBL25187902

SCHEMBL25187902

CN(C)c1ccc(Nc2ccc(CNO)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.47
▸ TSHR P16473 2/20 0.47
▸ TDP1 Q9NUW8 2/20 0.47
▸ CYP3A4 P08684 1/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ CA1 P00915 1/20 0.46
▸ CA2 P00918 1/20 0.46
▸ CA9 Q16790 1/20 0.46
▸ MAPT P10636 4/20 0.46
▸ NPC1 O15118 3/20 0.46
▸ RAB9A P51151 3/20 0.46
▸ L3MBTL1 Q9Y468 2/20 0.46
▸ HDAC1 Q13547 7/20 0.45
▸ HDAC6 Q9UBN7 6/20 0.45
▸ HDAC2 Q92769 5/20 0.45
▸ HDAC10 Q969S8 5/20 0.45
▸ HDAC8 Q9BY41 5/20 0.45
▸ MMP8 P22894 1/20 0.45
▸ HTT P42858 2/20 0.44
▸ KDM4E B2RXH2 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20904516 0.90 ALDH1A1 (0.56) ALDH1A1TSHRTDP1CYP3A4MAPK1
SCHEMBL5450701 0.81 ALDH1A1 (0.50) ALDH1A1TSHRTDP1CYP3A4MAPK1
SCHEMBL25189530 0.80 ALDH1A1 (0.57) ALDH1A1TDP1CA1CA2CA9
SCHEMBL222247 0.79 ALDH1A1 (0.65) ALDH1A1TSHRTDP1CYP3A4MAPK1
SCHEMBL9479616 0.79 ALDH1A1 (0.65) ALDH1A1TSHRTDP1CYP3A4MAPK1
SCHEMBL8548516 0.78 THRB (0.50) ALDH1A1TSHRTDP1CYP3A4MAPK1
SCHEMBL26154964 0.77 ALDH1A1 (0.50) ALDH1A1TSHRTDP1CYP3A4MAPK1
SCHEMBL25195421 0.76 IDO1 (0.67) ALDH1A1TSHRTDP1CYP3A4MAPK1
SCHEMBL856237 0.76 CA1 (0.70) ALDH1A1TSHRTDP1CYP3A4MAPK1
SCHEMBL25183891 0.74 CA1 (0.49) CA1CA2HDAC6HDAC8HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115151252-B Iron death inhibitor-diarylamine acetamides 维泰瑞隆有限公司 2024-08-27 — — CN disclosed
US-20230159492-A1 FERROPTOSIS INHIBITORS - DIARYLAMINE PARA-ACETAMIDES Sironax Ltd. (KY) 2023-05-25 — — US disclosed
US-20230159492-A1 FERROPTOSIS INHIBITORS - DIARYLAMINE PARA-ACETAMIDES Sironax Ltd. (KY) 2023-05-25 — — US disclosed
US-20230159492-A1 FERROPTOSIS INHIBITORS - DIARYLAMINE PARA-ACETAMIDES Sironax Ltd. (KY) 2023-05-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159492-A1 FERROPTOSIS INHIBITORS - DIARYLAMINE PARA-ACETAMIDES AIFM2, FECH, GPX4 ALDH1A1 395/4885TSHR 3876/4885TDP1 4083/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback